LISA BORG: Open Payments
NPI 1649316019 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$886 in 7 payments from 4 companies in 2025. Trend: 2023 $150 · 2024 $940 · 2025 $886
Food & beverage: $886
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $498 |
| Janssen Pharmaceuticals, Inc | 1 | $150 |
| Alkermes, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $113 |
Products named: CAPLYTA, INVEGA SUSTENNA, VIVITROL, Auvelity.
Industry payments across NY — which companies pay providers there.
